Pacheco GJD

Language: Spanish
References: 16
Page: 49-51
PDF size: 373.02 Kb.

ABSTRACT

Tuberculosis (TB) in patients with AIDS shows peculiar epidemiological, clinical, radiological, microbiological and therapeutical aspects. There are certain aspects which constitute relevant clinico-epidemiological elements: first, the presence of new risk factors, second, the high risk of becoming infected with the disease, third, the high rates of recurrence and mortality, and finally the high percentage of extrapulmonary clinical forms and cutaneous anergy. In the radiological, microbiological and therapeutic aspects we can distinguish other peculiarities such as the presence of “atipic” radiological patterns, the increase of the pharmacoresistence, the high incidence of adverse reactions to drugs and their malabsorption. We can conclude that AIDS has influenced in the modification of the tuberculosis clinical-epidemiological spectrum. Besides, to face with success this situation it is required coordinated, adequatly financed and easy to develop policies among different factors which emphasize in preventive actions on both AIDS and TB.

REFERENCES

1. Hopewell PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin infect Dis 1992;15: 540-47.

2. Pilheu JA. La tuberculosis frente al SIDA o la nueva epidemiología de la tuberculosis. Rev Argent del Tórax. 1992; 53(3-4): 3-6.

3. Colectivo Sol, AC. Abordando la TB y el VIH. Bol Acción en SIDA. 1996:1-24.

4. Canueto Quintero J, Bascuñana A, Vergara de Campos A, Torres-Tortosa M, Escribano JC, Sánchez A et al. Características clínicas y evolutivas de la tuberculosis extrapulmonar/ diseminada en los pacientes con SIDA. Estudio de 103 casos diagnosticados en la provincia de Cádiz. Rev Clin Esp 1994; (2): 87-97.

5. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974; 124: 1-16.

6. Crofton SJ.Tuberculosis clínica/Crofton SJ, Horne N; Miller F.- París: UICTER,1994:237.

7. Aguirrebengoa L, Montejo M, Urkijo JC et al. Tuberculosis y SIDA. Enferm Microbiol Clin. 1991; 9(7): 399-404.

8. Dooley SW, Villarino ME, Lawrence M. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992; 267: 2632-35.

9. Rose DN. The relationship between Tuberculosis and HIV infection. Occup Med 1994; 9(4): 575-87.

10. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factro alpha and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with mycobacterium tuberculosis. Infect Immun 1991; 59: 3021.

11. Rich EA, Ellner JJ. Pathogenesis of tuberculosis. In: Friedman LN, editor. Tuberculosis: Current Concepts and treatment. Florida: CRC Press. 1994: 27-51.

12. Barnes pf. La tuberculosis en los pacientes con infección por el virus de inmunodeficiencia humana (VIH). ¿Cuántas veces imita la Neumonía por Pneumocystis Carinii? Rev Argent del Tórax 1992; 53(3-4): 74.

13. Weltman AC, Rose DN. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York Cite Hospital. Arch Intern Med 1994; 154: 2161-67.

14. Cohn DL, Dobkin JF. Treatment and prevention of tuberculosis in HIV infection. AIDS 1993; 7(suppl.1): S195-202.

15. Peloquin CA, Berning SE. Infecction caused by Mycobacterium tuberculosis. Ann Pharmacother 1994; 28(1): 72-84.

16. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-infected patients. NEJM 1995; 332(5): 336-7.